Publicaciones en las que colabora con Luis García Ortiz (16)

2022

  1. Retinal blood vessel calibre and vascular ageing in a general Spanish population: A EVA study

    European Journal of Clinical Investigation, Vol. 52, Núm. 2

2020

  1. Association of Alk1 and Endoglin Polymorphisms with Cardiovascular Damage

    Scientific Reports, Vol. 10, Núm. 1

  2. Reference values of arterial stiffness parameters and their association with cardiovascular risk factors in the Spanish population. The EVA Study

    Revista Espanola de Cardiologia, Vol. 73, Núm. 1, pp. 43-52

2018

  1. Corrigendum: Association of VAV2 and VAV3 polymorphisms with cardiovascular risk factors

    Scientific reports

  2. Influence of angiogenic mediators and bone remodelling in paget´s disease of bone

    International Journal of Medical Sciences, Vol. 15, Núm. 11, pp. 1210-1216

2017

  1. Association of VAV2 and VAV3 polymorphisms with cardiovascular risk factors

    Scientific Reports, Vol. 7

2016

  1. Serum Superoxide Dismutase Is Associated with Vascular Structure and Function in Hypertensive and Diabetic Patients

    Oxidative Medicine and Cellular Longevity, Vol. 2016

2015

  1. Plasma cardiotrophin-1 as a marker of hypertension and diabetes-induced target organ damage and cardiovascular risk

    Medicine (United States), Vol. 94, Núm. 30

2014

  1. Relationship between target organ damage and blood pressure, retinal vessel calibre, oxidative stress and polymorphisms in VAV-2 and VAV-3 genes in patients with hypertension: A case-control study protocol (LOD- Hipertensión)

    BMJ Open, Vol. 4, Núm. 4

2012

  1. Osteoprotegerin is associated with cardiovascular risk in hypertension and/or diabetes

    European Journal of Clinical Investigation, Vol. 42, Núm. 5, pp. 548-556

2011

  1. Peripheral and central arterial pressure and its relationship to vascular target organ damage in carotid artery, retina and arterial stiffness. development and validation of a tool. the Vaso risk study

    BMC Public Health, Vol. 11

2010

  1. Afección renal subclínica y establecida en pacientes hipertensos de nuevo diagnóstico

    Medicina Clinica, Vol. 134, Núm. 6, pp. 246-253

  2. Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients

    BMC Medicine, Vol. 8

2009

  1. Effect of different antihypertensive treatments on Ras, MAPK and Akt activation in hypertension and diabetes

    Clinical Science, Vol. 116, Núm. 2, pp. 165-173

  2. Pulse pressure and nocturnal fall in blood pressure are predictors of vascular, cardiac and renal target organ damage in hypertensive patients (LOD-RISK study)

    Blood Pressure Monitoring, Vol. 14, Núm. 4, pp. 145-151

  3. Therapeutic implications of selecting the SCORE (European) versus the D'AGOSTINO (American) risk charts for cardiovascular risk assessment in hypertensive patients

    BMC Cardiovascular Disorders, Vol. 9